This cognitive ancillary study of a randomised trial covered 12 434 adults in China with type 2 diabetes. Participants were aged 50 or over and randomised to a systolic target below 120 or 140 mm Hg. Over a median 3.8 years, dementia or mild cognitive impairment occurred in 747 intensive and 783 standard participants. Rates were 3.69 and 3.89 per 100 person years, a hazard ratio of 0.96 (95% CI 0.86 to 1.06). In an MRI subset of 862, white matter lesion volume grew less with intensive treatment. The trial was open label, and only 605 participants had end-of-study MRI.
Why it is interesting: The trial tests whether a lower systolic target protects cognition in people with type 2 diabetes. Lesion growth on MRI slowed, but diagnosed dementia or mild cognitive impairment did not change over a median 3.8 years.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.